argenx logo

Territory Business Manager - Knoxville, TN

argenx

Knoxville, TN; Chattanooga, TNOnsitePosted 1 day ago$140,000 - $192,500/year
Full TimeSenior LevelCommercial & Pharma SalesBiotechnology
Original posting ↗

Summary

The Territory Business Manager (TBM) for the Neurology Franchise will drive demand generation through a focused approach on healthcare professionals, academic institutions, and specialty pharmacy/infusion providers. Through exemplary collaboration with internal and field-based partners and a patient-first mindset, the TBM will help deliver on quarterly sales objectives within their assigned geography. TBM's will report into the Business Leader.

Job description

The Territory includes Knoxville and Chattanooga.

Roles and Responsibilities

  • Travel within assigned geography and occasionally beyond
  • Territory planning and development of local market strategy
  • Collaborate with regional colleagues and cross-functional team members
  • Communicate and engage with assigned HCP's and affiliated staff
  • Consistently meet and exceed sales objectives
  • Effective utilization of market tools and resources
  • Timely submission of account plans and activity including CRM
  • Adhere to all argenx compliance policies, guidelines and approved sales messages

Skills and Competencies

  • Ability to sell collaboratively
  • High level of clinical, product, and business acumen
  • Problem solving
  • Working effectively together
  • Results Oriented
  • Capable in a virtual sales environment
  • Demonstrates ownership and accountability
  • Passionate about serving patients
  • Understanding of market access dynamics, emphasis on specialty pharmacy and buy & bill accounts

Education, Experience, and Qualifications

  • 5+ years of specialty/rare disease/biologics sales experience, neurology strongly preferred
  • Proven track record of consistent high sales performance
  • Adept at planning, organizing, and executing sales strategy
  • Demonstrate ability to collaborate with internal stakeholders
  • Ability to adapt to an ever-changing environment
  • Experienced in product launches
  • Align with core values of the organization – co-creation, humility, excellence, empowerment and innovation
  • Education: B.S. or B.A. degree preferred

Requirements

  • 5+ years of specialty/rare disease/biologics sales experience
  • Neurology experience strongly preferred
  • Proven track record of consistent high sales performance
  • Adept at planning, organizing, and executing sales strategy
  • Demonstrate ability to collaborate with internal stakeholders
  • Ability to adapt to an ever-changing environment
  • Experienced in product launches
  • B.S. or B.A. degree preferred

Benefits

  • Retirement Savings Plans
  • Health Benefits
  • Short-term Incentive Program
  • Long-term Incentive Program

Company overview

argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Founded in 2008 and headquartered in Amsterdam, Netherlands with major operations in Boston, Massachusetts, argenx is a commercial-stage, fully-integrated biopharma company developing a deep pipeline of differentiated antibody-based therapies. The company's core innovation engine is its Immunology Innovation Program (IIP), which partners with leading academic researchers to translate immunology breakthroughs into novel medicines. argenx has developed and commercialized VYVGART, the first approved FcRn blocker available in more than 30 countries for conditions like generalized myasthenia gravis (gMG), chronic inflammatory demyelinating polyneuropathy (CIDP), and immune thrombocytopenia (ITP). The company leverages its proprietary SIMPLE ANTIBODY™ platform technology based on llama immune systems to access novel disease biology targets, combined with antibody engineering technologies like NHANCE™ and ABDEG™ to enhance therapeutic properties. With over 1,500 employees globally and listed on both Euronext Brussels and Nasdaq, argenx maintains a robust pipeline including empasiprubart (C2 inhibitor) in Phase 3 trials and several earlier-stage experimental medicines targeting various autoimmune conditions.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.